Leverkusen, January 2014 – The main stories in the latest edition of research, the Bayer Scientific Magazine, deal with contemporary challenges in the worlds of medicine, agriculture and materials: which new treatments could help patients suffering from cancer or cardiovascular diseases in the future, how biological crop protection agents benefit global agriculture and how innovative material solutions contribute to more efficient wind power generation. The articles written to a high journalistic standard also outline the benefits of the new approaches, in keeping with the company mission "Bayer: Science For A Better Life." The term "companion diagnostics", for example, refers to specific diagnostic tests that are developed together with external cooperation partners and which in future will help to determine the treatment that is best suited to the individual condition of a cancer patient. In the cover story on "Medicine of the future", Bayer HealthCare's scientists also explain how new active ingredients may offer dual protection to two interconnected organs, the heart and the kidneys. Attractive photo sequences, lavishly illustrated graphics and interviews with scientists from universities and research institutions provide a wide-ranging insight into the company's work.
The research app: research as a multimedia experience
A new digital platform has been added for research, the Bayer Scientific Magazine. The magazine is now available at www.research.app.bayer.com and can be accessed with an internet browser on all platforms; whether on a smartphone or tablet or desktop PC, the app automatically adapts to suit the user's device. With multimedia story-telling in videos, 3D animations, image galleries, audio slideshows and animated infographics, the app provides a comprehensive insight into the world of research at Bayer. Each topic has a story check list that offers a quick overview of the challenges, solutions and benefits associated with each Bayer innovation. The app also shows how these innovations improve human quality of life. In addition, every article can be shared via the social media platforms Twitter and Facebook or sent by e-mail. The magazine is also available as a native app for tablet PCs and smartphones (operating systems: Android and iOS) for downloading from the respective stores.
Additional service for teachers: teaching materials on the iPad
In addition to the redesigned magazine section, the research internet website also offers more features: more than 50 infographics from the magazine can now be downloaded from the redesigned infographic database at http://www.research.bayer.com/en/graphic-download-medicine.aspx. As a supplement to the magazine, Bayer also offers interdisciplinary teaching materials for educators: the "Interactive teaching materials" service brings schoolbooks to life. Animations, infographics, video excursions and much more support natural science teaching. The interactive learning checks, concise educational contents and instructions for group work were developed in collaboration with educational specialists to provide real support for science teaching. This service can be downloaded as an iBook or PDF from http://www.research.bayer.com/en/teaching-materials.aspx and can also be downloaded free of charge from the Apple iBookstore. The topics include: "Plant-breeding 3.0", "Catalysis" and "How a drug is developed."
research, the Bayer scientific magazine, can be ordered free of charge by phone (+49 214/30-57546), fax (+49 214/30-57547) or e-mail (firstname.lastname@example.org).
The app can be accessed at www.research.app.bayer.com
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an innovation company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2012, Bayer employed some 110,000 people and had sales of EUR 39.7 billion. Capital expenditures amounted to EUR 1.9 billion, R&D expenses to EUR 3.0 billion. For more information, go to www.bayer.com.
Find more information at www.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those described in Bayer's public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.